BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38081959)

  • 21. [Diagnostic value of multiply biopsies and endocervical curettage on cervical lesions].
    Zhang L; Du H; Zhang W; Yang B; Wang C; Belinson JL; Wu R
    Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):263-7. PubMed ID: 26080937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
    Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
    Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
    Gunes AC; Ozgul N; Turkyılmaz M; Kara F; Unlu F; Ayhan A; Gultekin M
    Cancer Med; 2023 Dec; 12(24):21751-21760. PubMed ID: 37994572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
    JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of cytology and visual triage of human papillomavirus-positive women in cervical cancer prevention in India.
    Muwonge R; Wesley RS; Nene BM; Shastri SS; Jayant K; Malvi SG; Thara S; Sankaranarayanan R
    Int J Cancer; 2014 Jun; 134(12):2902-9. PubMed ID: 24272364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
    Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
    Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
    Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
    BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV testing with cytology triage for cervical cancer screening in routine practice.
    Louvanto K; Chevarie-Davis M; Ramanakumar AV; Franco EL; Ferenczy A
    Am J Obstet Gynecol; 2014 May; 210(5):474.e1-7. PubMed ID: 24373948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Grade Cervical Intraepithelial Neoplasia Detected by Colposcopy-Directed or Random Biopsy Relative to Age, Cytology, Human Papillomavirus 16, and Lesion Size.
    Chen Q; Du H; Pretorius RG; Wang C; Yang B; Wang G; Tang J; Belinson JL; Wu R
    J Low Genit Tract Dis; 2016 Jul; 20(3):207-12. PubMed ID: 26855144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
    Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
    Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
    Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidate HPV genotypes not included in the 9-valent vaccine for prevention of CIN 2-3.
    Gonzalez-Bosquet E; Gibert M; Serra M; Hernandez-Saborit A; Gonzalez-Fernandez A
    Int J Gynecol Cancer; 2020 Jul; 30(7):954-958. PubMed ID: 32467333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.